BDNF and Parkinson disease: Additionally, we have demonstrated that Nano-BDNF PEG-PLE presents clear benefits over unformulated BDNF in the treatment of Parkinson’s disease and ischemic stroke models in mice while preserving BDNF’s circulation and residence in affected areas [10,11].